News

Low-Calorie Sweeteners Affect Weight, Blood Sugar Less Than Sugar in Mouse Study

New research in mice suggests that low-calorie sweeteners cause only modest changes in blood sugar, insulin levels, insulin sensitivity, and weight gain, as compared with those induced by sugar. The study is published in the American Journal of Physiology — Regulatory, Integrative and Comparative Physiology.

Low-calorie sweeteners produced from both artificial and naturally occurring plant-based molecules are popular because they enhance the taste of food and drink without the high calorie count of sugar. Previous studies of the health impact of these products have garnered conflicting results. Some research has shown weight gain and altered blood glucose control as side effects of low-calorie sweeteners, while other evidence suggests that natural sweeteners such as stevioside improve glucose control. Much of the research on low-calorie sweeteners focuses on a single sweetener, which may be limiting because different sweeteners have different metabolic effects on the body.

In the new study, researchers studied mice in two different trials to determine weight changes and metabolic effects produced by artificial low-calorie sweeteners. In the first trial, the mice were given a randomly assigned low-calorie sweetened drink containing either saccharin, sucralose, or acesulfame potassium. The drink was available to the animals in addition to food and plain water over the course of 28 days. In the second trial, the mice were randomly assigned to a drink containing either saccharin, glucose, or a combination of the two sweeteners along with their normal diet.

The researchers used a mixture of saccharin and glucose for two reasons. People tend to consume low-calorie sweetened drinks together with carbohydrates as part of a meal or snack, which causes blood sugar to rise after a meal. Also, previous research has shown that the combination of saccharin and glucose impairs glucose tolerance more than either sweetener alone.

In the first trial, the investigators examined the impacts of the low-calorie sweeteners on body weight and blood sugar control but didn’t observe any changes. In the second trial, the mice exposed to glucose alone developed a higher percentage of body fat, enhanced blood sugar control, and increased insulin sensitivity. Although consumption of the saccharin caused a moderate rise in insulin levels, it failed to produce any changes in glucose tolerance, blood triglyceride levels, insulin sensitivity, or body fat composition. The metabolic changes induced by the saccharin and combination saccharin and glucose drink were much less pronounced than expected.

“To the extent that our results from mice are relevant to humans, they suggest that the metabolic impact of low-calorie sweeteners are minor compared to those produced by sugar,” explains John Glendinning, PhD, first author of the study and the Ann Whitney Olin Professor of Biological Sciences at Barnard College in New York City. “Future studies should determine whether diets containing different types of glucose-containing carbohydrates (eg, sucrose, maltodextrins, and starch) induce similar metabolic changes,” the authors wrote.